Over the past 12 months, 2 insiders at Cadrenal Therapeutics, Inc. filed 44 open-market SEC Form 4 transactions on CVKD: 0 purchases worth $0 and 44 sales worth $1.1M. Insiders have been net sellers over this period. The most recent filing was on Jun 26, 26.
| Date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 26, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 9.0K | $3.05 | $28K |
| Jun 25, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 2.1K | $3.00 | $6K |
| Jun 23, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 2.3K | $3.20 | $7K |
| Jun 22, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 9.2K | $3.55 | $33K |
| Jun 17, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 513 | $3.16 | $2K |
| Jun 16, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 3.6K | $3.18 | $11K |
| Jun 15, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 3.7K | $3.58 | $13K |
| Jun 12, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 13.0K | $3.94 | $51K |
| Jun 11, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 1.5K | $4.12 | $6K |
| Jun 10, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 3.5K | $4.21 | $15K |
| Jun 9, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 13.0K | $4.06 | $53K |
| Jun 8, 26 | Quang X PhamChairman, CEO and Interim CFO | SELL | 5.9K | $4.38 | $26K |
| Jun 5, 26 | Quang X PhamCEO and Chairman | SELL | 2.1K | $4.42 | $9K |
| Jun 4, 26 | Quang X PhamCEO and Chairman | SELL | 3.9K | $4.41 | $17K |
| Jun 3, 26 | Quang X PhamCEO and Chairman | SELL | 2.3K | $4.26 | $10K |
| Jun 2, 26 | Quang X PhamCEO and Chairman | SELL | 349 | $4.46 | $2K |
| May 29, 26 | Quang X PhamCEO and Chairman | SELL | 303 | $5.01 | $2K |
| May 28, 26 | Quang X PhamCEO and Chairman | SELL | 3.0K | $4.93 | $15K |
| May 22, 26 | Quang X PhamCEO and Chairman | SELL | 1.2K | $5.69 | $7K |
| May 12, 26 | Quang X PhamCEO and Chairman | SELL | 3.3K | $5.28 | $17K |
| May 11, 26 | Quang X PhamCEO and Chairman | SELL | 6.5K | $5.76 | $37K |
| Dec 29, 25 | Matthew K SzotChief Financial Officer | SELL | 9.9K | $6.97 | $69K |
| Oct 27, 25 | Quang X PhamCEO and Chairman | SELL | 1.3K | $13.99 | $18K |
| Oct 27, 25 | Matthew K SzotChief Financial Officer | SELL | 1.8K | $13.99 | $25K |
| Oct 24, 25 | Quang X PhamCEO and Chairman | SELL | 1.1K | $14.03 | $16K |
| Oct 24, 25 | Matthew K SzotChief Financial Officer | SELL | 1.8K | $13.99 | $25K |
| Oct 13, 25 | Quang X PhamCEO and Chairman | SELL | 1.8K | $14.15 | $25K |
| Oct 13, 25 | Matthew K SzotChief Financial Officer | SELL | 1.8K | $14.07 | $25K |
| Oct 9, 25 | Quang X PhamCEO and Chairman | SELL | 1.8K | $14.02 | $25K |
| Oct 9, 25 | Matthew K SzotChief Financial Officer | SELL | 1.7K | $13.99 | $24K |
| Oct 6, 25 | Matthew K SzotChief Financial Officer | SELL | 107 | $13.99 | $1K |
| Oct 2, 25 | Quang X PhamCEO and Chairman | SELL | 500 | $14.13 | $7K |
| Oct 1, 25 | Quang X PhamCEO and Chairman | SELL | 881 | $14.01 | $12K |
| Oct 1, 25 | Matthew K SzotChief Financial Officer | SELL | 1.7K | $13.99 | $24K |
| Sep 29, 25 | Quang X PhamCEO and Chairman | SELL | 419 | $14.01 | $6K |
| Sep 29, 25 | Matthew K SzotChief Financial Officer | SELL | 100 | $14.00 | $1K |
| Sep 25, 25 | Quang X PhamCEO and Chairman | SELL | 6.8K | $14.09 | $96K |
| Sep 25, 25 | Matthew K SzotChief Financial Officer | SELL | 10.9K | $14.05 | $153K |
| Sep 24, 25 | Quang X PhamCEO and Chairman | SELL | 2.6K | $13.99 | $36K |
| Sep 24, 25 | Matthew K SzotChief Financial Officer | SELL | 1.5K | $14.00 | $21K |
| Aug 28, 25 | Quang X PhamCEO and Chairman | SELL | 1.2K | $13.99 | $17K |
| Aug 28, 25 | Matthew K SzotChief Financial Officer | SELL | 400 | $14.00 | $6K |
| Aug 27, 25 | Quang X PhamCEO and Chairman | SELL | 3.8K | $13.99 | $54K |
| Aug 27, 25 | Matthew K SzotChief Financial Officer | SELL | 1.6K | $14.00 | $22K |
| Oct 5, 23 | John Raymond MurphyDirector | BUY | 2.7K | $0.69 | $2K |
| Oct 4, 23 | John Raymond MurphyDirector | BUY | 17.3K | $0.70 | $12K |
| Sep 5, 23 | Quang X PhamCEO and Chairman | BUY | 20.0K | $0.91 | $18K |
| Sep 1, 23 | Quang X PhamCEO and Chairman | BUY | 20.0K | $0.93 | $19K |
| Mar 21, 23 | John Raymond MurphyDirector | BUY | 10.0K | $1.39 | $14K |
| Mar 16, 23 | John Raymond MurphyDirector | BUY | 20.0K | $1.67 | $33K |
Over the past 12 months, insiders at Cadrenal Therapeutics, Inc. filed 0 open-market purchases worth $0 and 44 sales worth $1.1M on CVKD, which makes them net sellers over the period. The most recent Form 4 was filed on Jun 26, 26.
The largest recent open-market CVKD insider purchase in our data was $33K by John Raymond Murphy, Director, filed on Mar 16, 23.
2 different insiders at Cadrenal Therapeutics, Inc. filed open-market SEC Form 4 transactions on CVKD over the last 12 months.
InsiderTape plots every CVKD insider buy and sell directly on the price chart and flags new SEC Form 4 filings as they arrive, with cluster detection and buy/sell pressure. The data updates daily from SEC EDGAR.
InsiderTape plots every Cadrenal Therapeutics, Inc. insider buy and sell on the price chart, with buy/sell pressure, cluster detection, and alerts the moment new Form 4s hit. Start a free 7-day trial, cancel anytime.
Does it work? In five years of data, insider clusters beat the Russell 2000 about 60% of the time and the CFO's buy was the sharpest signal of all. See the backtest →
START FREE TRIAL →